Enevia Health invites you to AMRS 2026, an international event for multidisciplined researchers, clinicians, medical specialists and families/ carers of Autistic people. This event is specifically dedicated to high-support Autism, a subgroup representing approximately 30% of the Autistic population. Based on a global prevalence of 1% (1 in 100), this corresponds to an estimated 1.35 million individuals in the European Union and over 24 million worldwide. This subgroup of Autistic individuals requires substantial, or very substantial, daily support due to limited functional communication, co-occurring intellectual disability, and significant behavioural or medical complexities. Despite the scale and severity of need, this population remains significantly under-represented in research and greatly underserved in clinical pathways.

The purpose of AMRS is to provide structured dialogue among clinicians, researchers and Autism specialists to assess current frameworks, stratification, and integrated care models. The focus is across lifespan, with particular attention to medical complexity, co-morbidities, and outcomes that matter to individuals and families. The summit’s scientific event program includes state-of-the-art lectures, thematic sessions, moderated discussions and a poster exhibition. We hope to foster on-site collaboration turning high-potential ideas into feasible, impactful future initiatives.

There will be special focus on emerging medical research that is reshaping the understanding of complex phenotypes, including systems biology, multi-omics, neuro- immunology, genomics, and digital tools which supports further research and care planning. The mission of AMRS is to unite clinicians, scientists, industry innovators, policymakers, and families around a shared goal: improving health outcomes, reducing suffering, and developing actionable solutions for the most complex and underserved Autistic individuals.

We look forward to welcoming you to Sitges, Barcelona on 5-7 November 2026!